Abstract
There are many laboratory biofilm models available which can be used to assess the susceptibility of these distinctive resistant phenotypes. The complexities of these models vary considerably and indeed, the antimicrobial susceptibility of biofilms grown in these different models are also not standardised. It is clear that such methods are necessary for the testing of antibiotics and antimicrobial agents since these persistent communities are far more resistant than their planktonic counterparts. Therefore, it is now apparent that standardised tests such as MIC are no longer appropriate on their own to fully characterise susceptibility. There has also been a growing realisation that bacteria are growing as biofilms in almost every health-care setting and are, thus, a major contributing factor to the difficulty of treating infections. There is a pressing need for the models outlined in this chapter to test both current and novel anti-biofilm compounds and materials.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Gould IM (1994) Risk factors for acquisition of multiply drug-resistant Gram-negative bacteria. Eur J Clin Microbiol Infect Dis 13:30–38
Nisbet LJ (1982) Current strategies in the search for bioactive microbial metabolites. J Chem Technol Biotechnol 32:251–270
Slocombe B (1994) The future of antibacterial chemotherapy. Zentralbl Bakteriol 281:346–352
Nichols WW (1991) Biofilms, antibiotics and penetration. Rev Med Microbiol 2:177–181
Nickel JC, Rueseska I, Wright JB, Costerton JW (1985) Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother 27:619–624
Widmer AF, Frei R, Rajacic Z, Zimmerli W (1990) Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 162:96–102
Wright TL, Ellen RP, Lacroix J-M, Sinnadurai S, Mittleman MW (1997) Effects of metronidazole on Porphyromonas gingivalis biofilms. J Periodontal Res 32:473–477
Larsen T, Fiehn NE (1996) Resistance of Streptococcus sanguis biofilms to antimicrobial agents. APMIS 104:280–284
Buckingham-Meyer K, Goeres DM, Hamilton MA (2007) Comparative evaluation of biofilm disinfectant efficacy tests. J Microbiol Methods 70:236–244
Govan JR, Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60:539–574
Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP (2000) Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407:762–764
Gardner LR, Stewart PS (2002) Action of glutaraldehyde and nitrite against sulfate-reducing bacterial biofilms. J Ind Microbiol Biotechnol 29:354–360
ASTM International (2007) E2196-07: Standard test method for quantification of a Pseudomonas aeruginosa biofilm grown with shear and continuous flow using a rotating disk reactor. Annual book of ASTM standards, vol 11.05. ASTM International, West Conshohocken, PA
Murga R, Miller JM, Donlan RM (2001) Biofilm formation by gram-negative bacteria on central venous catheter connectors: effect of conditioning films in a laboratory model. J Clin Microbiol 39:2294–2297
ASTM International (2007) E2562-07: Standard test method for quantification of Pseudomonas aeruginosa grown with high shear and continuous flow using a CDC Biofilm Reactor. Annual book of ASTM standards, vol 11.05. ASTM International, West Conshohocken, PA
Pratten J, Wilson M (1999) Antimicrobial susceptibility and composition of microcosm dental plaques supplemented with sucrose. Antimicrob Agents Chemother 43:1595–1599
Norwood DE, Gilmour A (2000) The growth and resistance to sodium hypochlorite of Listeria monocytogenes in a steady-state multispecies biofilm. J Appl Microbiol 88:512–520
Al-Bakri AG, Gilbert P, Allison DG (2004) Immigration and emigration of Burkholderia cepacia and Pseudomonas aeruginosa between and within mixed biofilm communities. J Appl Microbiol 96:455–463
Elvers KT, Leeming K, Lappin-Scott HM (2002) Binary and mixed population biofilms: time-lapse image analysis and disinfection with biocides. J Ind Microbiol Biotechnol 29:331–338
Chin MYH, Busscher HJ, Evans R, Noar J, Pratten J (2006) Early biofilm formation and the effects of antimicrobial agents on orthodontic bonding materials in a parallel plate flow chamber: a novel approach. Eur J Orthod 28:1–7
Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A (1999) The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37:1771–1776
Sandoe JA, Wysome J, West AP, Heritage J, Wilcox MH (2006) Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms. J Antimicrob Chemother 57:767–770
Ali L, Khambaty F, Diachenko G (2006) Investigating the suitability of the Calgary Biofilm Device for assessing the antimicrobial efficacy of new agents. Bioresour Technol 97:1887–1893
Spratt DA, Pratten J, Wilson M, Gulabivala K (2001) An in vitro evaluation of the antimicrobial efficacy of irrigants on biofilms of root canal isolates. Int Endod J 34:308–317
Carmen JC, Nelson JL, Beckstead BL, Runyan CM, Robison RA, Schaalje GB, Pitt WG (2004) Ultrasonic-enhanced gentamicin transport through colony biofilms of Pseudomonas aeruginosa and Escherichia coli. J Infect Chemother 10:193–199
Charaf S, Bakich L, Falbo DM (1999) A model biofilm for efficacy assessment of antimicrobials versus biofilm bacteria. In: Wimpenny J, Gilbert P, Walker J, Brading M, Bayston R (eds) Biofilms – The good, the bad, and the ugly. Bioline, Cardiff, UK, pp 171–177
Ha KR, Psaltis AJ, Butcher AR, Wormald PJ, Tan LW (2008) In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope 118:535–540
Pope CF, Gillespie SH, Pratten JR, McHugh TD (2007) Fluoroquinolone-Resistant mutants of Burkholderia cepacia. Antimicrob Agents Chemother 52:1201–1203
Honraet K, Nelis HJ (2006) Use of the modified robbins device and fluorescent staining to screen plant extracts for the inhibition of S. mutans biofilm formation. J Microbiol Methods 64:217–224
Mikuniya T, Kato Y, Kariyama R, Monden K, Hikida M, Kumon H (2005) Synergistic effect of fosfomycin and fluoroquinolones against Pseudomonas aeruginosa growing in a biofilm. Acta Med Okayama 59:209–216
Vorachit M, Lam K, Jayanetra P, Costerton JW (1993) Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic discs to ceftazidime and co-trimoxazole. Antimicrob Agents Chemother 37:2000–2002
Hodgson AE, Nelson SM, Brown MR, Gilbert P (1995) A simple in vitro model for growth control of bacterial biofilms. J Appl Bacteriol 79:87–93
Folkesson A, Haagensen JA, Zampaloni C, Sternberg C, Molin S (2008) Biofilm induced tolerance towards antimicrobial peptides. PLoS ONE 3:e1891
Neut D, de Groot EP, Kowalski RS, van Horn JR, van der Mei HC, Busscher HJ (2005) Gentamicin-loaded bone cement with clindamycin or fusidic acid added: biofilm formation and antibiotic release. J Biomed Mater Res A 73:165–170
Kinniment SL, Wimpenny JW, Adams D, Marsh PD (1996) Development of a steady-state oral microbial biofilm community using the constant-depth film fermenter. Microbiology 142:631–638
Coombe RA, Tatevossian A, Wimpenny JWT (1982) Bacterial thin films as in vitro models for dental plaque. In: Frank RM, Leach SA (eds) Surface and colloid phenomena in the oral cavity: methodological aspects. IRL, London, pp 239–249
Peters AC, Wimpenny JW (1988) A constant-depth laboratory film fermentor. Biotechnol Bioeng 32:263–270
McBain AJ, Bartolo RG, Catrenich CE, Charbonneau D, Ledder RG, Rickard AH, Symmons SA, Gilbert P (2003) Microbial characterization of biofilms in domestic drains and the establishment of stable biofilm microcosms. Appl Environ Microbiol 69:177–185
Ready D, Roberts AP, Pratten J, Wilson M, Mullany P (2002) Composition and antibiotic resistance profile of microcosm dental plaques before and after exposure to tetracycline. J Antimicob Chemother 49:769–775
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Pratten, J., Ready, D. (2010). Use of Biofilm Model Systems to Study Antimicrobial Susceptibility. In: Gillespie, S., McHugh, T. (eds) Antibiotic Resistance Protocols. Methods in Molecular Biology, vol 642. Humana Press. https://doi.org/10.1007/978-1-60327-279-7_16
Download citation
DOI: https://doi.org/10.1007/978-1-60327-279-7_16
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-278-0
Online ISBN: 978-1-60327-279-7
eBook Packages: Springer Protocols